Trial intelligence / Profile preview

Total Therapy Study XIV for ALL

NCT00187005Phase 3Terminated

Sponsor
St. Jude Children's Research Hospital
Start
Jul 1998
Primary completion
Jul 2002
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of methotrexate in acute lymphoblastic leukemia (ALL), sponsored by St. Jude Children's Research Hospital. Started Jul 1998; status: terminated.

02

Drugs

methotrexate
03

Conditions

acute lymphoblastic leukemia (ALL)

Beyond the preview

Go deeper on NCT00187005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00187005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call